Research, Development, And Testing Services - Insider Trading Data

Insiders are officers, directors, or significant investors. This page shows insider sentiment and transactions for the Research, industry. Research shows that insider trades are predictive of future stock returns. By examining insider trades for an industry, we can understand what well-informed people think of the overall future industry prospects.

Research, Development, And Testing Services - Insider Buy/Sell Ratio

Insider selling and buying is a useful indicator for analyzing the market because it serves as a proxy for their optimism or pessimism in their own companies. By looking at ratio of total selling and buying across the entire market, we might be able to draw some conclusions about the future market.

We offer two charts here. The first one shows the total dollar volume of buying and selling by insiders. The second chart shows the ratio of the number of insiders selling, vs. the number of insiders buying. In both charts, we filter out trades made by indirect holders (such as trusts), and 10% owners (who, although considered an 'insider' by the SEC, do not actually manage the companies in which they are considered insiders).

Corporate Insider Buy Sell Ratio (Dollar Volume) - Research, Development, And Testing Services
Corporate Insider Buy Sell Ratio (Insider Count) - Research, Development, And Testing Services
Research, Development, And Testing Services - Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b5-1 automatic trading plan will have an X in the column marked 10b-5.

Tran
Date
Security Form Insider Code 10b5-1 Direct Share
Price
Shares
Changed
2026-04-24 MEDP / Medpace Holdings, Inc. 4 EWALD STEPHEN P M - Exercise D 138.87 3,500
2026-04-24 MEDP / Medpace Holdings, Inc. 4 Brady Kevin M. M - Exercise D 138.87 7,000
2026-04-23 ONMD / OneMedNet Corporation 4 Kosasa Thomas P - Purchase D 0.89 280,898
2026-04-23 IQV / IQVIA Holdings Inc. 4 LEONARD JOHN M. A - Award D 1,571
2026-04-23 IQV / IQVIA Holdings Inc. 4 DANHAKL JOHN G By Trust A - Award I 1,571
2026-04-23 IQV / IQVIA Holdings Inc. 4 Burt Carol By Trust A - Award I 1,571
2026-04-23 IQV / IQVIA Holdings Inc. 4 GOGGINS COLLEEN A A - Award D 1,571
2026-04-21 OABI / OmniAb, Inc. 4 Crouse Steven C. M - Exercise D 13,333
2026-04-21 OABI / OmniAb, Inc. 4 Gotwals Philip J M - Exercise D 13,333
2026-04-17 INCY / Incyte Corporation 4 CAGNONI PABLO J S - Sale D 96.50 -18,667
2026-04-17 INCY / Incyte Corporation 4 CAGNONI PABLO J M - Exercise D 71.93 12,590
2026-04-17 INCY / Incyte Corporation 4 CAGNONI PABLO J M - Exercise D 64.25 6,077
2026-04-15 INCY / Incyte Corporation 4 Meury William M - Exercise D 125,000
2026-04-15 INCY / Incyte Corporation 4 Stein Steven H A - Award D 39,049
2026-04-15 INCY / Incyte Corporation 4 CAGNONI PABLO J A - Award D 27,892
2026-04-15 MXCT / MaxCyte, Inc. 4 Ahuja Parmeet A - Award D 187,500
2026-04-07 OABI / OmniAb, Inc. 4 FOEHR MATTHEW W S - Sale D 1.49 -19,244
2026-04-07 OABI / OmniAb, Inc. 4 GUSTAFSON KURT A S - Sale D 1.49 -6,913
2026-04-07 OABI / OmniAb, Inc. 4 Berkman Charles S S - Sale D 1.49 -7,157
2026-04-07 OABI / OmniAb, Inc. 4 Berkman Charles S M - Exercise D 13,542
2026-04-07 OABI / OmniAb, Inc. 4 GUSTAFSON KURT A M - Exercise D 13,542
2026-04-07 OABI / OmniAb, Inc. 4 FOEHR MATTHEW W M - Exercise D 36,459
2026-04-01 ONMD / OneMedNet Corporation 4 Yu Jeffrey P - Purchase D 0.83 903,614
2026-04-01 NEO / NeoGenomics, Inc. 4 Stone Warren M - Exercise D 17,562
2026-04-01 NEO / NeoGenomics, Inc. 4 Zook Anthony P. M - Exercise D 140,498
2026-04-01 NEO / NeoGenomics, Inc. 4 Zook Anthony P. F - Taxes D -45,453
2026-04-01 NEO / NeoGenomics, Inc. 4 Stone Warren F - Taxes D -6,911
2026-04-01 ONMD / OneMedNet Corporation 4 Yu Jeffrey A - Award D 0.83 219,429
2026-03-31 MEDP / Medpace Holdings, Inc. 4 Kraft Robert O. M - Exercise D 33
2026-03-31 MEDP / Medpace Holdings, Inc. 4 Carley Brian T M - Exercise D 36
2026-03-31 MEDP / Medpace Holdings, Inc. 4 McCarthy Cornelius P. III M - Exercise D 29
2026-03-31 INCY / Incyte Corporation 4 BAKER BROS. ADVISORS LP See Footnotes A - Award I 421
2026-03-31 INCY / Incyte Corporation 4 BAKER BROS. ADVISORS LP See Footnotes A - Award I 421
2026-03-31 INCY / Incyte Corporation 4 HARRIGAN EDMUND A - Award D 94.12 269
2026-03-31 INCY / Incyte Corporation 4 Clancy Paul J A - Award D 94.12 265
2026-03-27 MXCT / MaxCyte, Inc. 4 Masoud Maher A - Award D 300,000
2026-03-25 INCY / Incyte Corporation 4 Trotta Matteo F - Taxes D 92.23 -537
2026-03-18 MEDP / Medpace Holdings, Inc. 4 BURWIG SUSAN E M - Exercise D 166.73 12,000
2026-03-17 INCY / Incyte Corporation 4 CAGNONI PABLO J S - Sale D 94.24 -18,667
2026-03-17 MXCT / MaxCyte, Inc. 4 Swirsky Douglas J S - Sale D 0.815 -10,142
2026-03-17 MEDP / Medpace Holdings, Inc. 4 GEIGER JESSE J S - Sale D 455.30 -31,707
2026-03-17 MEDP / Medpace Holdings, Inc. 4 GEIGER JESSE J M - Exercise D 138.87 31,707
2026-03-17 INCY / Incyte Corporation 4 CAGNONI PABLO J M - Exercise D 61.18 7,166
2026-03-17 INCY / Incyte Corporation 4 CAGNONI PABLO J M - Exercise D 64.25 11,501
2026-03-12 ABSI / Absci Corporation 4 Busch Andreas P - Purchase D 2.29 100,000
2026-03-12 NRC / NRC Health 4 Rau Jason Russell A - Award D 60,000
2026-03-04 CRL / Charles River Laboratories International, Inc. 4 Girshick Birgit Revocable Trust G - Gift I -328
2026-03-03 CRL / Charles River Laboratories International, Inc. 4 LaPlume Joseph W P - Purchase D 174.54 25
2026-03-03 ABSI / Absci Corporation 4/A McClain Sean F - Taxes D 2.80 -25,316
2026-03-03 ABSI / Absci Corporation 4 Walker Shelby J. F - Taxes D 2.80 -9,825
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)